This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will evaluate the use of mobile devices to extract vital signs to monitor patients with asthma. The $459,127 award to M5 Enterprise, LLC (doing business as Emedical Sentry) aims to improve the detection and management of asthma attacks through remote patient monitoring. The goal is to enhance telehealth by incorporating video-based vital sign capture, which can extend physician reach, improve healthcare delivery efficiency, and provide greater access for at-risk populations. This innovative technology seeks to leverage common commercial off-the-shelf devices to enable earlier intervention for acute asthma symptoms, ultimately improving quality of life and reducing healthcare costs.
Generated 8/13/24, 8:36 AM